Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Van Cutsem

Showing results (161-170 of 251) with videos related to

Pageof 26
Sort By:
ESMO Open|December 13, 2021
Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC studyJ Tabernero, L Velez, T L Trevino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2017
A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplificationE Van Cutsem, Y-J Bang, W Mansoor, et al.
Acta Gastro-Enterologica Belgica|October 2, 2021
Evaluating the accuracy of three international guidelines in identifying the risk of malignancy in pancreatic cysts: a retrospective analysis of a surgical treated populationA Vanden Bulcke, J Jaekers, H Topal, et al.
Acta Gastro-Enterologica Belgica|May 1, 2009
Diagnostic pitfalls in digestive neuroendocrine tumoursI Borbath, F Jamar, T Delaunoit, et al.
Acta Gastro-Enterologica Belgica|May 1, 2009
The antiproliferative effect of somatostatin analogs: clinical relevance in patients with neuroendocrine gastro-entero-pancreatic tumoursC Verslype, S Carton, I Borbath, et al.
ESMO Open|December 1, 2022
Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancerE Van Cutsem, H Hochster, K Shitara, et al.
Acta Gastro-Enterologica Belgica|May 1, 2009
The potential role of targeted therapies in the management of neuroendocrine tumoursG Verset, I Borbath, T Delaunoit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2019
Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studiesJ Taieb, Q Shi, L Pederson, et al.
British Journal of Cancer|June 13, 2015
Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesisL De Smedt, J Lemahieu, S Palmans, et al.
Cancer Treatment Reviews|December 24, 2014
Optimising translational oncology in clinical practice: strategies to accelerate progress in drug developmentR Stahel, J Bogaerts, F Ciardiello, et al.
Pageof 26

Showing results (161-170 of 251) with videos related to

Sort By:
Pageof 26
ESMO Open|December 13, 2021
Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC studyJ Tabernero, L Velez, T L Trevino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2017
A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplificationE Van Cutsem, Y-J Bang, W Mansoor, et al.
Acta Gastro-Enterologica Belgica|October 2, 2021
Evaluating the accuracy of three international guidelines in identifying the risk of malignancy in pancreatic cysts: a retrospective analysis of a surgical treated populationA Vanden Bulcke, J Jaekers, H Topal, et al.
Acta Gastro-Enterologica Belgica|May 1, 2009
Diagnostic pitfalls in digestive neuroendocrine tumoursI Borbath, F Jamar, T Delaunoit, et al.
Acta Gastro-Enterologica Belgica|May 1, 2009
The antiproliferative effect of somatostatin analogs: clinical relevance in patients with neuroendocrine gastro-entero-pancreatic tumoursC Verslype, S Carton, I Borbath, et al.
ESMO Open|December 1, 2022
Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancerE Van Cutsem, H Hochster, K Shitara, et al.
Acta Gastro-Enterologica Belgica|May 1, 2009
The potential role of targeted therapies in the management of neuroendocrine tumoursG Verset, I Borbath, T Delaunoit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2019
Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studiesJ Taieb, Q Shi, L Pederson, et al.
British Journal of Cancer|June 13, 2015
Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesisL De Smedt, J Lemahieu, S Palmans, et al.
Cancer Treatment Reviews|December 24, 2014
Optimising translational oncology in clinical practice: strategies to accelerate progress in drug developmentR Stahel, J Bogaerts, F Ciardiello, et al.
Pageof 26